Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)

Chris P. Verschoor; Laura Haynes; Graham Pawelec; Mark Loeb; Melissa K. Andrew; George A. Kuchel; Janet E. McElhaney

doi:10.3389/fragi.2021.718966

Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)

Chris P. Verschoor, Laura Haynes, Graham Pawelec, Mark Loeb, Melissa K. Andrew, George A. Kuchel, Janet E. McElhaney

Health Professions

科研成果: 期刊稿件 › 评论/辩论 › 同行评审

1 引用（Scopus）

源语言	英语
文章编号	718966
期刊	Frontiers in Aging
卷	2
DOI	https://doi.org/10.3389/fragi.2021.718966
出版状态	已出版 - 2021

!!!ASJC Scopus Subject Areas

老化
遗传学
分子生物学
生理学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.3389/fragi.2021.718966

其它文件与链接

指纹

探究 'Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)' 的科研主题。它们共同构成独一无二的指纹。

引用此

Verschoor, C. P., Haynes, L., Pawelec, G., Loeb, M., Andrew, M. K., Kuchel, G. A., & McElhaney, J. E. (2021). Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110). Frontiers in Aging, 2, 文章 718966. https://doi.org/10.3389/fragi.2021.718966

Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110). / Verschoor, Chris P.; Haynes, Laura; Pawelec, Graham 等.
在: Frontiers in Aging, 卷 2, 718966, 2021.

科研成果: 期刊稿件 › 评论/辩论 › 同行评审

Verschoor, CP, Haynes, L, Pawelec, G, Loeb, M, Andrew, MK, Kuchel, GA & McElhaney, JE 2021, 'Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)', Frontiers in Aging, 卷 2, 718966. https://doi.org/10.3389/fragi.2021.718966

@article{bb7d98def39e4c92a19ac0f07ccef4ec,

title = "Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)",

keywords = "cell-mediated immune responses, cytomegalovirus, frailty index, granzyme B, high-dose vs. standard-dose split-virus influenza vaccine, interferon-gamma, interleukin-10, older adults",

author = "Verschoor, {Chris P.} and Laura Haynes and Graham Pawelec and Mark Loeb and Andrew, {Melissa K.} and Kuchel, {George A.} and McElhaney, {Janet E.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 Verschoor, Haynes, Pawelec, Loeb, Andrew, Kuchel and McElhaney.",

year = "2021",

doi = "10.3389/fragi.2021.718966",

language = "English",

volume = "2",

journal = "Frontiers in Aging",

issn = "2673-6217",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Corrigendum

T2 - Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)

AU - Verschoor, Chris P.

AU - Haynes, Laura

AU - Pawelec, Graham

AU - Loeb, Mark

AU - Andrew, Melissa K.

AU - Kuchel, George A.

AU - McElhaney, Janet E.

PY - 2021

Y1 - 2021

KW - cell-mediated immune responses

KW - cytomegalovirus

KW - frailty index

KW - granzyme B

KW - high-dose vs. standard-dose split-virus influenza vaccine

KW - interferon-gamma

KW - interleukin-10

KW - older adults

UR - http://www.scopus.com/inward/record.url?scp=85162237739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85162237739&partnerID=8YFLogxK

U2 - 10.3389/fragi.2021.718966

DO - 10.3389/fragi.2021.718966

M3 - Comment/debate

AN - SCOPUS:85162237739

SN - 2673-6217

VL - 2

JO - Frontiers in Aging

JF - Frontiers in Aging

M1 - 718966

ER -